Uffe Ravnskov

Born 1934 in Copenhagen, Denmark.

Graduated 1961 from the University of Copenhagen with an M.D.

1961-1967 various appointments at surgical, roentgenological, neurological, pediatric and medical departments in Denmark and Sweden.

1968-79 various appointments at the Department of Nephrology, and the Department of Clinical Chemistry, University Hospital, Lund, Sweden; 1975-79 as an assistant professor at the Department of Nephrology.

1973 PhD at the University of Lund. A specialist in internal medicine and nephrology.

1979-2000 a private practitioner. Since 1979 an independent researcher.

Honoured by the Skrabanek Award 1999 given by Trinity College of Dublin, Ireland for original contributions in the field of medical scepticism.

A member of the expert panel of the Journal of the Swedish Medical Association (Läkartidningen) and the Swedish medical journal Tidskriften Medikament.

Dr. Ravnskov is the spokesman of THINCS , The International Network of Cholesterol Skeptics

On the Swedish medical Web-journal The Rondel , you will find a personal view on Dr. Ravnskov by Bo Norberg, MD, PhD, and a review of his career .
His own story is available in Swedish

Address:
Magle Stora Kyrkogata 9, S-223 50 Lund, Sweden

Tel: +46 46 145022 E-mail

Papers and books published in English about cholesterol and the diet-heart idea:

Ravnskov, U. Lowering cholesterol concentrations and mortality. British Medical Journal 1990;301: 814.
Ravnskov U. An elevated serum cholesterol is secondary, not causal, in coronary heart disease. Medical Hypotheses 1991;36:238-41.
Ravnskov U. Atherogenicity and thrombogenicity indices. The Lancet 338, 1328, 1991.
Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome . British Medical Journal 1992;305: 15-19. Letters: British Medical Journal 1992;305:420-422, and 717.
Ravnskov U. The fragile links of the diet-heart chain. Nutrition Quarterly 1992;16:19-21.
Ravnskov U. Cardiovascular disease in developing countries. British Medical Journal 1993;306:145-6.
Ravnskov U. Dietary fats and blood lipids as cardiovascular risk factors in the general population. A critical overview. Proceedings of the I. World Congress of Dairy Products in Human Health and Nutrition. Madrid 1993. Rotterdam: Balkema 1994, p 361-369.
Ravnskov U. Reducing serum cholesterol. Lower cholesterol of doubtful benefit to anyone. British Medical Journal 1993;307:125.
Ravnskov U. Coronary atherosclerosis on angiography-progress or regress and why? Circulation 1993;88:1358-9.
Ravnskov U. Hypercholesterolemia does not cause coronary heart disease - evidence from the nephrotic syndrome. Nephron 1994;66:356-7.
Ravnskov U. Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified . British Medical Journal 1994;308:1038.
Ravnskov U. Is there a cause-effect relationship between high blood cholesterol and atherosclerosis? Workshop on cholesterol-lowering trials. National Heart, Lung and Blood Institute, Bethesda 1994.
Ravnskov U. What do angiographic changes after cholesterol lowering mean? The Lancet 1994;344:1297.
Ravnskov U. Is intake of trans-fatty acids and saturated fat causal in coronary heart disease? Circulation 1994;90:2568-9.
Ravnskov U. Doing the right thing: stop worrying about cholesterol. Circulation 1994;90:2572-3.
Ravnskov U. Quotation bias in reviews of the diet-heart idea. Journal of Clinical Epidemiology 1995;48:713-719.
Ravnskov U. Implications of 4S evidence on baseline lipid levels. The Lancet 1995;346:181.
Ravnskov U. Beneficial effects of simvastatin may be due to non-lipid actions . British Medical Journal 1995;311:1436-1437.
Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. Journal of Clinical Epidemiology 1998;51:443-460. Read also a dissent to the paper: Golomb BA. Dietary fats and heart disease-dogma challenged? and my answer; same journal and same issue. This paper won the Skrabanek award 1999
Ravnskov U. Why heart disease mortality is low in France. Authoŕs hypothesis is wrong . British Medical Journal 1999;319:255
Ravnskov U. VAT and fat. Evidence is contradictory . British Medical Journal 2000;320:1470
Ravnskov U. Prevention of atherosclerosis in children . The Lancet 2000;355:69.
Ravnskov U. The Cholesterol Myths. Washington: New Trends Publishing , 2000; ISBN 0-9670897-0-0
Ravnskov U. Cholesterol and all-cause mortality in Honolulu . The Lancet 2001; 358: 1907.
Ravnskov U. Diet-heart disease hypothesis is wishful thinking. British Medical Journal 2002; 324: 238
Ravnskov U, Allan C, Atrens D, Enig MG, Groves B, Kaufman J, Kroneld R, Rosch PJ, Rosenman R, Werkö L, Nielsen JV, Wilske J, Worm N. Studies of dietary fat and heart disease . Science 2002; 295:1464-1465.
Ravnskov U. Statins as the new Aspirin. Conclusions from the heart protection study were premature. British Medical Journal 2002;324:789.
Ravnskov U. Is atherosclerosis caused by high cholesterol? Quarterly Journal of Medicine 2002; 95: 397-403. This paper was also selected for publication in the third issue of South African Excerpts Edition of the QJM 2002
Ravnskov U. A hypothesis out-of-date: The diet-heart idea. Journal of Clinical Epidemiology, 2002 Nov;55(11):1057-63. Same issue: Dissent by W.S.Weintraub, and Reply by U. Ravnskov

Papers and books in Swedish, Danish, Finnish or German about cholesterol and the diet-heart idea

Ravnskov U. Är fleromättat fett nyttigt? Läkartidningen 1991;88:1058
Ravnskov U. Kolesterolmyten (The Cholesterol Myth). Stockholm : Streifferts, 1991; ISBN 91-7886-085-7.
Ravnskov U. Kolesteroli. Helsinki : Art House, 1992 (Finnish translation of Kolesterolmyten); ISBN 951-884-078-4.
Ravnskov U. Kolesterolmyten. Månedsskrift for praktisk Lægegerning 1991;70:131-138
Ravnskov U. Hvad er det rigtige svar i kolesteroldebatten? Ugeskrift for Læger 1992;154:1716
Ravnskov U. Kolesterol och hälsa: En titt under mattan. Livsmedelsteknik1992;4:7-8.
Ravnskov U. Tveksamheter om kolesterol. Suomen Lääkarilehti 1993;48:1063-1064.
Ravnskov U. Flera tveksamheter om kolesterol. Suomen Lääkarilehti 1993;48:1716-1717.
Ravnskov U. Tvivlsomme råd om kolesterolscreening hos børn. Ugeskrift for Læger 1993;155:1886-1887.
Ravnskov U. Nya tongånger från USA. Kolesterolkampanjen ifrågasättas. Läkartidningen 1993;90:2528-2529.
Ravnskov U. Stoppa kolesterolkampanjen! Läkartidningen 1993;90:4587-4588.
Ravnskov U. Slutreplik om kolesterol. Läkartidningen 1994;91:117-118
Ravnskov U. Livet forkortes når kolesterolet sænkes. Ugeskrift for Læger 1993;155:3678-3679.
Ravnskov U. Kolesterolsænkende lægemidler. Ugeskrift for Læger 1994;156:329
Ravnskov U. Ukritisk referat af kolesterolartikler.Ugeskrift for Læger 1994;156:4479
Ravnskov U. Fedtsyrer og forvirrende signaler. Ugeskrift for Læger 1995;157:1534-1535.
Ravnskov U. Keys eller kaos.Ugeskrift for Læger 1995;157:3210
Ravnskov U. Är fleromättat fett en orsak till manlig sterilitet? Läkartidningen 1996;93:2040
Ravnskov U. Auktoriteter kräver tolkningsföreträde. Läkartidningen 1997;95:1024-1025.
Ravnskov U. Myten om det mättade och det fleromättade fettet. Tidskriften Medikament 1998;3(4):44-51 och 1998;3(5):48-53
Ravnskov U. "Medelhavsdietens" förträfflighet är en myt. Läkartidningen 1998;95:4749-4750.
Ravnskov U. Är motion överlägsen statinbehandling? Läkartidningen 2000;97:2177
Ravnskov U. Varför blir kranskärl aterosklerotiska? Läkartidningen 2000; 98: 41
Ravnskov U. Nya intressanta fakta i Science och BMJ...Synen på matens fett håller på att förändras. Tidskriften Medikament 2001:5(4)

Ravnskov U. Kolesterol är ofarligt. Dagens Nyheter (Stockholm) February 2, 1990.
Ravnskov U. De äter världens fetaste mat - utan att få hjärtinfarkt. Land (Stockholm) July 12, 1991
Ravnskov U. Fedtkampanjen - humor eller kvaksalveri? Information (Copenhagen) May 25, 1992.
Ravnskov U. Goddag kolesterol - økseskaft. Information (Copenhagen) June 17, 1992.
Ravnskov U. Fortsat kolesterolgalskab. Information (Copenhagen) June 26, 1992
Ravnskov U. Ny hjärtmedicin ger cancer, Dagens Nyheter (Stockholm) April 22, 1997
Ravnskov U. Ingen risk med fett. Dagens Nyheter (Stockholm) July 7, 1997

Ravnskov U. On renal handling of plasma proteins. Scandinavian Journal of Urology and Nephrology 1973;7 suppl 20. [Thesis]
Ravnskov U, Johansson BG, Ljunger L. Proteinuria in pigs with experimentally induced renal damage. Contributions to Nephrology 1975;1:50-61.
Ravnskov U, Karatson A. Renal handling of human ß2-microglobulin in the rat: The importance of sham-operation. Acta Physiologica Scandinavica 1975;94:467-471.
Ravnskov U. Low molecular weight proteinuria in association with paroxysmal myoglobinuria. Clinical Nephrology 1975;3:65-69.
Ekman R, Johansson BG, Ravnskov U. Renal handling of Zn alfa2-glycoprotein as compared with that of albumin and the retinol-binding protein. Journal of Clinical Investigation 1976;57:945-954.
Ravnskov U, Johansson BG. Isolation and partial characterization of a porcine low molecular weight protein occurring in plasma and urine. International Journal of Biochemistry 1976;7:579-583.
Hultberg B, Ravnskov U. The excretion of N-acetyl-ß-glucosaminidase in glomerulonephritis. Clinical Nephrology 1981;15:33-38.
Ravnskov U. Soap is the major cause of dysuria. The Lancet 1, 1027-8,1983.
Ravnskov U. Exposure to organic solvents - a missing link in acute poststreptococcal glomerulonephritis? Acta Medica Scandinavica 1978;203:351-356.
Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and hydrocarbon exposure - a case control study. Acta Medica Scandinavica 1979; 205:575-579.
Ravnskov U, Lundström S, Nordén Å. Hydrocarbon exposure and glomerulonephritis: evidence from patients' occupations. The Lancet 1983;2:1214-16.
Ravnskov U. Possible mechanisms of hydrocarbon-associated glomerulonephritis. Clinical Nephrology 1985;23:294-298.
Ravnskov U. Influence of hydrocarbon exposure on the course of glomerulonephritis. Nephron 1986;42:156-160.
Ravnskov U. Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damage. American Journal of Kidney Diseases 1988;12:250-251.
Ravnskov U. Non-systemic glomerulonephritis: Exposure to nephro- and immunotoxic chemicals is primary and predisposes to immunologic harassment. Medical Hypotheses 30, 115-122, 1989.
Ravnskov U. The subepithelial formation of immune complexes in membranous glomerulonephritis may be harmless and secondary to allergic or toxic factors. Scandinavian Journal of Immunology 1998;48:469-474.
Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. British Journal of Clinical Pharmacology 1999;47:203-210.
Ravnskov U. Hydrocarbons may worsen renal function in glomerulonephritis: a meta-analysis of the case-control studies . American Journal of Industrial Medicine 2000;37:599-606.
Ravnskov U. Hydrocarbon exposure may cause glomerulonephritis and worsen renal function:evidence based on Hilĺs criteria for causality . Quarterly Journal of Medicine 2000;93:551-556.
Ravnskov U. Suicide of the nephron is preventable. The Lancet 2001;357 (May 12)